Home Blog Page 227

Vientiane Completes New 9.3-Kilometer Mekong Embankment

A picture of hand over ceremony. (Photo by Lao Economic daily)

On 1 July, Vientiane officially opened a new 9.3-kilometer stretch of Mekong riverfront featuring parks, walking and cycling paths, sports facilities, and flood protection infrastructure following the completion of Phase II of the Mekong River Integrated Management Project.

The new embankment extends from Wat Nak village in Sisattanak District to Hatdokkeo village in Hadsayfong district, serving 19 villages and adding 13 public parks, a riverside promenade, boat landings, street lighting, sidewalks, and drainage systems.

Construction began in February 2022 using a riprap design that employs large stones to reduce erosion and withstand floods expected once every 100 years.

The USD 67.56 million project was financed through a USD 57.6 million low-interest loan from South Korea, with the Lao government contributing USD 9.96 million.

The new embankment extends Vientiane’s riverfront protection system, which began with Phase I in 2014. That earlier phase stretches 12 kilometers from Kaoliew Village in Sikhoittabong District to Wat Nak Village in Sisattanak District and includes Chao Anouvong Park.

Several of the new parks opened to the public in June, adding green space and recreational areas for residents. The completed riverfront now offers expanded opportunities for walking, jogging, cycling, and other outdoor activities along the Mekong River.

China-Laos Low-Carbon Project Expected to Cut Emissions by More Than 1,200 Tons Annually

The picture used for illustration only, this is the the development zone.

The Vientiane-Saysettha Low-Carbon Demonstration Zone is expected to reduce carbon emissions by more than 1,200 tons annually through a range of clean energy and low-emission technologies, according to the China International Development Cooperation Agency (CIDCA).

According to CIDCA, the project has introduced solar-powered street lights, electric buses, new-energy trucks, environmental monitoring vehicles, and environmental law enforcement vehicles to promote greener urban development in Laos.

Tang said the initiative has improved urban services and environmental management in the demonstration zone while creating jobs and supporting business operations for hundreds of Chinese and regional companies based there.

The Vientiane-Saysettha Low-Carbon Demonstration Zone is one of 10 low-carbon pilot projects launched by China in partner countries under its South-South climate cooperation program.

Officially inaugurated in 2022, the zone spans about 11.5 square kilometers in Vientiane and is one of the largest Laos-China cooperation projects. Designed as both an industrial park and a new urban area, it is expected to attract about USD 5 billion in investment.

In addition to low-carbon infrastructure, the initiative includes training programs to strengthen Laos’ environmental management capacity.

Dr Savitha Dharan Takes the Helm as CEO of Thomson Hospital Kota Damansara

Appointment reinforces the hospital’s commitment to clinical excellence, strategic growth and delivering exceptional patient care.


KOTA DAMANSARA, MALAYSIA – Media OutReach Newswire – 2 July 2026 – Thomson Hospital Kota Damansara (Thomson) is pleased to announce the appointment of Dr Savitha Dharan as its Chief Executive Officer, effective 1 July 2026.

Dr Savitha Dharan Takes the Helm as CEO of Thomson Hospital Kota Damansara

Dr Savitha brings more than 20 years of experience in clinical practice, hospital operations, strategic partnerships, business development and healthcare leadership. She holds a Bachelor of Medicine, Bachelor of Surgery and Bachelor in the Art of Obstetrics (MB BCh BAO) from the Royal College of Surgeons in Ireland (RCSI) and completed executive education in Managing Health Care Delivery at Harvard Business School.

Following a decade in clinical practice across the public and private sectors, Dr Savitha progressed into healthcare leadership, holding senior roles within recognised private healthcare groups and institutions. As a Chief Executive Officer, she has successfully led business transformation, operational excellence, service innovation and strategic growth initiatives.

Welcoming the appointment, Dato’ Dr. Adzuan Rahman, Group Chief Executive Officer of TMC Life Sciences Berhad, said:

“We are delighted to welcome Dr Savitha to the TMC Life Sciences family. Her strong clinical foundation, proven leadership and strategic vision make her the right leader to guide Thomson Hospital Kota Damansara into its next phase of growth. We are confident she will further strengthen the hospital’s position as a leading multidisciplinary tertiary healthcare provider while advancing our commitment to clinical excellence, innovation and value-driven care.”

Dr Savitha’s appointment underscores Thomson’s commitment to clinician-led leadership, recognising that strong clinical expertise, coupled with sound management capabilities, forms the foundation of patient-centred decision-making and the delivery of high-quality healthcare.

Commenting on her appointment, Dr Savitha stated, “It is a privilege to lead Thomson Hospital Kota Damansara, an organisation with a strong reputation for delivering exceptional patient care. As both a clinician and a healthcare leader, I believe the best outcomes are achieved by empowering our people, embracing innovation, and continuously improving patient experience. I look forward to working alongside our dedicated teams to build on the hospital’s strong foundation and shape its next chapter of excellence.”

Hashtag: #ThomsonHospital

The issuer is solely responsible for the content of this announcement.

About Thomson Hospital Kota Damansara

Established in 2008, Thomson Hospital Kota Damansara (THKD) is the flagship hospital of TMC Life Sciences Berhad (TMCLS) located in a prime alcove of Kota Damansara, Selangor. THKD is expected to grow to a 554-bedded hospital with additional specialist centres and operating theatres as part of the Group’s expansion plan. THKD sets new standards in healthcare through comprehensive facilities and excellent service for both our local and international patients. The Hospital offers medical and surgical services from over 160 reputable specialist consultants covering more than 60 medical and surgical sub-specialties.

For more information, please visit thomsonhospitals.com or follow THKD on social media platforms @thomsonhospitalKD.

LinqAlpha Raises $22 Million to Build the Alpha Intelligence Layer for Global Public Markets

LinqAlpha turns each investor’s own research into AI agents that surface market-moving signals before they are priced in.

NEW YORK, July 2, 2026 /PRNewswire/ — LinqAlpha, the AI-native company building the Alpha Intelligence Layer for global public markets, today announced $22 million in Series A funding. The round was anchored by AVP, Atinum Investment, and GFT Ventures, with participation from a global syndicate of strategic financial institutions and venture platforms.

Founded by Jacob Choi, Subeen Pang, Jin Kim, and Hojun Choi, LinqAlpha brings together former Goldman Sachs analysts and MIT computer science PhDs. Since launch, the platform has seen rapid adoption, serving over 70 financial institutions across the U.S., Europe, and Asia, including sell-side sales, trading, and research teams at leading investment banks, as well as buy-side clients such as Causeway Capital Management LLC and Schonfeld Strategic Advisors LLC. Collectively, LinqAlpha’s buy-side clients manage more than $5 trillion in assets.

The company was built to address a critical inflection point in modern finance: public markets have become too fast, global, and interconnected for traditional research workflows. A supply-chain disruption in Asia, a policy shift in Europe, a social-media signal, an earnings call, and a credit-market move can all become part of the same thesis within hours. The challenge for institutional investors is no longer finding information; it is synthesizing thousands of moving signals into differentiated judgment before consensus catches up.

“The first wave of AI in finance made analysts faster. The next wave changes what they can know,” said Hojun Choi, co-founder and co-CEO of LinqAlpha. “The edge no longer comes from retrieving information; it comes from systems that surface market-moving signals before they are priced in.”

To deliver this edge, LinqAlpha enables institutional teams to deploy specialized AI agents that learn each user’s unique investment framework.

“In effect, LinqAlpha builds a second brain for every investment team: one that turns accumulated research into actionable insight across liquid public markets,” said Jacob Choi, co-founder and co-CEO of LinqAlpha. “Instead of a generic model’s average answer, each team gets agents that reason in the context of its own thesis history and evolve with its feedback and market view.”

“Most AI tools in finance help professionals retrieve information faster or automate repetitive work,” said Manish Agarwal, General Partner at AVP. “LinqAlpha is addressing a larger opportunity: building systems that help institutional investors discover differentiated insights in public markets that reward speed, context, and proprietary judgment.”

Alongside the lead investors, the round was oversubscribed with participation from a deep bench of strategic financial institutions and venture platforms across the U.S., Europe, and Asia. The new capital will be used to expand LinqAlpha’s global team—now headquartered in New York—deepen integrations across market and alternative datasets, and accelerate the deployment of its multi-agent platform across equities, macro, credit, and multi-asset strategies.

About LinqAlpha

LinqAlpha is a New York-based AI company building the Alpha Intelligence Layer for global public markets. Its platform lets institutional investors deploy specialized AI agents that learn each user’s investment framework and synthesize data into actionable insight. More than 70 financial institutions across the U.S., Europe, and Asia use LinqAlpha to support investment research and decision-making, including buy-side clients that collectively manage more than $5 trillion in assets.

For more information, visit www.linqalpha.com.

Notes to Editors

The Series A global syndicate includes strategic participation from SBI Investment and Z Venture Capital in Japan; Betatron Venture Group, East Ventures, and SV Investment across Southeast Asia and Hong Kong SAR; Samsung Securities, Mirae Asset Venture Investment, Mirae Asset Capital, NH Investment & Securities, Shinhan Venture Investment, and Hana Ventures in South Korea; and NuVentures in India.

Traveloka and Marriott International Partner to Bring the World’s Leading Hotel Brands Closer to Southeast Asia’s Travelers

Traveloka and Marriott International enter multi-year distribution agreement, making Marriott’s full portfolio of properties more visible for travelers across Indonesia and Southeast Asia to discover, compare and book

JAKARTA, Indonesia, July 2, 2026 /PRNewswire/ — Traveloka, Southeast Asia’s leading all-in-one travel tech platform, today announced a signed agreement with Marriott International, the world’s leading hospitality group with a portfolio of 10,000 properties across 146 countries and territories. The agreement designates Traveloka as Marriott’s Certified Online Travel Partner, establishing direct connectivity between Marriott’s portfolio inventory and Traveloka’s online distribution platform.

Traveloka, Southeast Asia's leading all-in-one travel tech platform, today announced a signed agreement with Marriott International, the world's leading hospitality group with a portfolio of 10,000 properties across 146 countries and territories. The agreement designates Traveloka as Marriott’s Certified Online Travel Partner, establishing direct connectivity between Marriott’s portfolio inventory and Traveloka’s online distribution platform. [From left to right] Tejveer Singh Bedi, Vice President of Commercial, Traveloka; Yady Guitana, Chief Financial Officer, Traveloka; John Toomey, Chief Commercial Officer, Asia Pacific excluding China, Marriott International; and Christopher Chung, Senior Director of Sales and Distribution, Indonesia & Malaysia, Marriott International.
Traveloka, Southeast Asia’s leading all-in-one travel tech platform, today announced a signed agreement with Marriott International, the world’s leading hospitality group with a portfolio of 10,000 properties across 146 countries and territories. The agreement designates Traveloka as Marriott’s Certified Online Travel Partner, establishing direct connectivity between Marriott’s portfolio inventory and Traveloka’s online distribution platform. [From left to right] Tejveer Singh Bedi, Vice President of Commercial, Traveloka; Yady Guitana, Chief Financial Officer, Traveloka; John Toomey, Chief Commercial Officer, Asia Pacific excluding China, Marriott International; and Christopher Chung, Senior Director of Sales and Distribution, Indonesia & Malaysia, Marriott International.

This means travelers in Indonesia and Southeast Asia will have access to real-time pricing and broader inventory availability to Marriott’s brands spanning luxury brands such as JW Marriott and W Hotels, premium brands such as Westin and Sheraton, and select brands such as Moxy and Aloft.

The partnership comes as Southeast Asia continues to emerge as one of the world’s fastest-growing travel markets. The region’s tourism sector is projected to grow from USD 35.5 billion in 2025 to USD 67.4 billion by 2031, while accounting for 15.4% of global travel demand. The direct connection between Marriott and Traveloka elevates visibility of Marriott properties in high-growth regional platforms, enhances speed-to-market and better engages travelers in Indonesia and Southeast Asia.

Demand for Marriott properties on Traveloka has grown strongly in recent months, with searches rising significantly across the platform. Travelers across the region are increasingly booking Marriott stays in Asia Pacific including Indonesia’s key cities, led by Four Points in Makassar, Surabaya, Medan, and Bandung, as well as Sheraton and Marriott Hotels, a signal of rising regional appetite for Marriott’s portfolio on the market.

“Indonesia remains one of Marriott International’s most exciting markets in the region, and we see tremendous opportunity to expand our presence and connect more travelers with our diverse portfolio of brands and experiences. Our collaboration with Traveloka strengthens our ability to engage travelers at every stage of their journey, making discovery and booking more seamless than ever. As Southeast Asia’s all-in-one travel tech platform, Traveloka is an important strategic partner, helping us broaden our reach, unlock new opportunities, and deliver greater choice and convenience to travelers across Indonesia,” said John Toomey, Chief Commercial Officer, Asia Pacific excluding China, Marriott International.

Marriott  currently operates nearly 90 properties across Indonesia and continues to expand through a robust development pipeline. Across Southeast Asia, Marriott is also growing its presence in markets such as Vietnam, Thailand, and Malaysia, supported by continued investments through 2030.

“At Traveloka, we help travelers find the right stay at the right moment — and increasingly, that means understanding intent before a traveler has finalized their plans,” said Yady Guitana, Chief Financial Officer, Traveloka. “When a hospitality company of Marriott’s standing chooses to expand access to its portfolio through our all-in-one travel platform, it reflects the trust the world’s leading travel brands place in Traveloka’s reach and traveler insight across Southeast Asia. By combining Marriott’s world-class portfolio with our regional data and AI-powered recommendations, we can deliver a more relevant booking experience while supporting Marriott’s continued growth in the region.”

The collaboration reinforces Traveloka’s role as a trusted growth partner for leading global travel brands seeking to engage Southeast Asia’s highly active travelers. By combining Marriott’s portfolio with Traveloka’s technology, regional reach, and traveler insights, both companies aim to create greater value for travelers while contributing to the continued growth of the region’s tourism ecosystem.

About Traveloka

Traveloka is Southeast Asia’s leading all-in-one travel tech platform, bringing flights, hotels, activities, travel insurance, and eSIM together in a single app. Founded in 2012, Traveloka now operates across Australia, Indonesia, Japan, Malaysia, the Philippines, Singapore, South Korea, Thailand, and Vietnam. With over 140 million app downloads, Traveloka was named Best Travel App at the Sensor Tower APAC Awards. With access to over 2 million hotels worldwide and 24/7 live chat support, Traveloka’s mission is to make travel more accessible and enjoyable for everyone across the region and beyond.

About Marriott International

Marriott International, Inc. (Nasdaq: MAR) is based in Bethesda, Maryland, USA, and encompasses a portfolio of compelling brands across luxury, premium, select, midscale, extended stay, and all-inclusive, with approximately 10,000 properties in 146 countries and territories, as of June 11, 2026. Marriott franchises, operates, and licenses hotel, residential, timeshare, yacht, outdoor, and other lodging products all around the world. The company offers Marriott Bonvoy ® , its highly awarded travel platform. For more information, please visit our website at www.marriott.com, and for the latest company news, visit www.marriottnewscenter.com. In addition, connect with us on Facebook and @MarriottIntl on X and Instagram.

TrueHealth Medical lands on HKEX as the first Hong Kong-listed percutaneous surgical robotics player, with a 216.96% debut rally


HONG KONG SAR – EQS Newswire – 2 July 2026 – On June 30, 2026, Guangdong TrueHealth Medical Technology Development Co., Limited (referred to as “TrueHealth Medical” or the “Company”, stock code: 02697.HK) has made its debut on the Main Board of the Hong Kong Stock Exchange, becoming the first HKEX-listed specialist in percutaneous surgical robotics. At market close, the Company’s stock settled at HK$400.0, representing an increase of HK$273.8 from its IPO offer price of HK$126.2, marking a 216.96% surge on its trading debut. Total trading volume hit HK$320 million, and the Company’s total market capitalization stood at HK$14.259 billion based on the closing price.

TrueHealth Medical drew heavy investor attention on its trading debut, building on robust pre-listing gray market sentiment. Ahead of the IPO, Futu Securities’ gray market sessions saw the stock hit a peak of HK$358, representing a 183.7% premium to the offer price. The upbeat market sentiment underscores strong investor appetite for the underserved niche segment of percutaneous puncture and ablation surgical robots.

Founded in 2018 as outlined in its prospectus, TrueHealth Medical specializes in the research, development and commercialization of percutaneous puncture and ablation robotic systems in China. Its flagship percutaneous surgical robot lineup comprises four variants: TH-S1, TH-S, TH-S Pro and TH-SA. All four hold Class III medical device registrations issued by the National Medical Products Administration (NMPA), cleared for navigation and positioning during percutaneous procedures on solid abdominal and pulmonary organs in adult patients. The TH-S model has received NMPA accreditation as a China-first innovation.

Beyond its core systems, the Company’s pipeline extends to percutaneous microwave ablation robotics. Its flagship TH-X MW system, approved for liver and lung tumor treatment, has secured NMPA recognition as a world-first innovation, while the TH-X HMW system is cleared solely for liver tumor interventions. The Company holds a full-spectrum product matrix spanning puncture navigation and positioning, microwave ablation therapy and pipeline candidates.

On industry leadership, research from CIC Consulting ranks TrueHealth Medical as China’s market leader by both shipment volume and revenue for percutaneous surgical robots in 2025, commanding respective market shares of 36.4% by shipment volume and 28.0% by revenue. As of the latest practicable date, 21 percutaneous surgical robotic systems have won NMPA approval nationwide, five of which belong to TrueHealth Medical – making the Company the earliest and most prolific developer of cleared devices in this specialized segment.

On commercialization, TrueHealth Medical booked annual revenues of RMB1.791 million in 2024 and RMB12.178 million in 2025. A total of six robotic systems were delivered throughout 2025, including two TH-S, one TH-P, one TH-S Pro and two TH-X MW. With an expanding roster of approved systems, broadening clinical adoption and maturing sales networks, the Company stands at a pivotal transition from product validation to scaled commercial growth.

Its Hong Kong listing equips TrueHealth Medical with capital markets backing to accelerate commercialization of core hardware, advance R&D for existing and pipeline systems, and scale manufacturing and go-to-market capabilities. The Company will continue building an intelligent robotics portfolio centered on percutaneous positioning and precision therapy, delivering cutting-edge minimally invasive solutions for oncology diagnosis and treatment.

Speaking at the listing ceremony, Cheong Hou Iam, the chairperson, executive director and general manager, commented: “TrueHealth Medical stays committed to resolving unmet clinical pain points via technological innovation. We focus on the R&D and commercialization of percutaneous puncture and ablation robotics. Drawing on deep technical expertise and extensive clinical validation, we iterate our products and broaden our offerings to build a robust moat in precision minimally invasive treatment. Surgical robotics is now entering a golden era, boosted by vast market prospects. Leveraging our first-mover advantage and industrial resources, we will capitalize on industry tailwinds, unlock full value and deliver sustainable returns to all our shareholders and investors.”

Hashtag: #TrueHealthMedical

The issuer is solely responsible for the content of this announcement.

About TrueHealth Medical Technology Development Co., Limited

A nationally accredited “Little Giant” enterprise (Specialized, Sophisticated, Distinctive & Innovative), Guangdong TrueHealth Medical Technology Development Co., Limited leverages artificial intelligence and robotic control technologies to develop and commercialize intelligent robots for soft tissue puncture diagnosis and organ repair. Its core offerings cover percutaneous puncture navigation and microwave ablation guided systems. The ZhenYiDa® percutaneous puncture navigation and positioning system holds NMPA China-first certification, while the ZhenYiDa® navigation and positioning microwave ablation system is accredited as a world-first innovation by NMPA. The Company undertakes key projects under China’s 14th Five-Year National Key R&D Program, with its products featured in national flagship schemes including high-end medical device roll-out initiatives, AI medical device innovation program and the Catalog of Outstanding Domestic Medical Devices. TrueHealth Medical aims to deploy AI and surgical robotics to advance precision, minimally invasive therapeutic solutions for widespread clinical use.

Fosun International Garners Five Awards from Corporate Governance Asia

Chen Qiyu and Xu Xiaoliang, Co-CEOs of Fosun International win Asia’s Best CEO from Corporate Governance Asia

Fosun International receives Sustainable Asia Award 2026, Best Environmental Responsibility Award and Best Corporate Communications Award

HONG KONG, July 2, 2026 /PRNewswire/ — On 30 June 2026, Corporate Governance Asia presented the 16th Asian Excellence Award. Chen Qiyu and Xu Xiaoliang, Executive Directors and Co-CEOs of Fosun International Limited (“Fosun International”, “Fosun” or the “Group”) (HKEX stock code: 00656) were both honored with Asia’s Best CEO. In addition, Fosun International received Sustainable Asia Award 2026, Best Environmental Responsibility Award and Best Corporate Communications Award.

Corporate Governance Asia is one of the most authoritative and influential corporate governance journals in the Asia Pacific region. The award recognizes outstanding industry leaders and enterprises that excelled in financial performance, corporate governance, corporate social responsibility, environmental protection, corporate communications, and investor relations over the past year. Other award recipients of the 16th Asian Excellence Award include well-known Asia Pacific companies such as Sino Land, Sun Hung Kai Properties, Bank of China (Hong Kong), China Mobile, China Telecom, China Unicom, China Communications Services, and PetroChina, etc.

Recognizing Excellence in Business Performance and ESG Practices

According to Corporate Governance Asia, in 2025, amid rapid global economic transformation and ongoing technological breakthroughs, Fosun maintained strong strategic focus, concentrating on its core businesses, pursuing steady development, and actively strengthening the operational capabilities of its advantageous industries, demonstrating solid operational resilience. In a complex external business environment, Chen Qiyu and Xu Xiaoliang, as CEOs of a large global private enterprise, have consistently driven Fosun’s high-quality development through the twin drivers of “innovation” and “globalization”. At the same time, they have actively advanced the deep integration of the Group’s ESG into its businesses to build a core competitive advantage for sustainable development, consistently contributing to a better world. Therefore, Chen Qiyu and Xu Xiaoliang were awarded Asia’s Best CEO.

Chen Qiyu, Executive Director and Co-CEO of Fosun International, said, “We are deeply honored to receive several prestigious awards from Corporate Governance Asia, including Asia’s Best CEO and the Sustainable Asia Award. These accolades recognize not only individual achievements but also reflect the collective efforts of the entire Fosun team. Over the years, we communicate transparently and efficiently with various stakeholders and rating agencies. Our relentless efforts in the ESG domain have garnered much external recognition. By adhering to innovation driven development and global operations, we continuously optimize resource allocation and focus our strengths on innovative research, ensuring our innovative achievements benefit the world. Upholding the philosophy of ‘Innovation for Good Health’, we will leverage original innovation to strengthen the foundation of sustainable development and steadily advance toward a more resilient and efficient sustainability journey.”

Xu Xiaoliang, Executive Director and Co-CEO of Fosun International, said, “Fosun’s globalization journey has evolved from ‘Combining China’s Growth Momentum with Global Resources’ to ‘Combining Global Resources with China’s Capabilities’. Fosun has consistently leveraged global resources to deliver more high-quality products and services to families around the world. With an increasingly sophisticated global business presence, Fosun has operated responsibly across more than 40 countries and regions, improving lives worldwide and creating sustainable value. As a global company rooted in China, Fosun began integrating ESG principles at an early stage, reflecting values deeply embedded in the Group’s DNA and corporate culture. Since its founding, Fosun has upheld its original aspiration of ‘Contribution to Society’, striving not only to create commercial value but also to generate broader social impact. Looking ahead, Fosun will actively respond to national strategies, implement ‘dual carbon’ goals, promote rural revitalization, expand impact across global communities in areas such as healthcare, educational equity, community construction, culture and art. The ultimate goal is to help more families enjoy healthier, happier, and wealthier lives.”

Advancing Global Sustainable Development with Outstanding ESG Performance

Corporate Governance Asia highlighted that Fosun has consistently advanced sustainable development through “innovation” and “globalization”, continuously improving its ESG system, actively addressing climate change and social challenges, and demonstrating outstanding achievements in green development, biodiversity conservation, public health, social welfare, etc. As a result, Fosun was honored with Sustainable Asia Award 2026, Best Environmental Responsibility Award and Best Corporate Communications Award. These accolades not only affirm Fosun’s outstanding performance in promoting global sustainable development and fulfilling corporate social responsibility, but also highlight its steadfast dedication to ESG knowledge sharing and climate advocacy.

Despite global economic, environmental, and social uncertainties in 2025, Fosun remained steadfast in its sustainability commitment and made remarkable strides. Fosun International’s MSCI ESG rating has been upgraded to the highest rating AAA. It has maintained a Hang Seng Sustainability Rating of AA-. It has also been included in S&P Global’s Sustainability Yearbook 2026 and consistently ranked among the top 1% in China. Its FTSE Russell ESG score rose to 4.2 (maximum score: 5) and has been included in the FTSE4Good Index Series for the fifth consecutive time.

Actively Responding to Climate Change and Protecting Biodiversity

In response to climate change and low-carbon transition, Fosun actively responds to the national “dual carbon” goals by promoting carbon neutrality and energy conservation and emissions reduction. In 2021, Fosun made a commitment to society – “strive to peak carbon emissions by 2028 and achieve carbon neutrality by 2050”. Fosun has formulated strategies for climate change mitigation and adaptation to align with the 1.5°C temperature control target set in the Paris Agreement. Building on its commitment to achieve carbon neutrality by 2050, Fosun has set a mid-term target to reduce the intensity of Scope 1 and Scope 2 GHG emissions by 20% by 2034, using 2024 as the base year. This reflects Fosun’s rigorous management of operational emissions and demonstrates the Group’s commitment and execution in advancing low-carbon transition.

In addition to actively addressing climate change, Fosun also places great importance on biodiversity conservation. In 2018, Atlantis Sanya under Fosun Tourism Group officially established an aquatic wildlife rescue station. Over the years, it has rescued a total of 42 wild sea turtles. On 23 May this year, World Turtle Day, the Sea Turtle Shelter at the Atlantis Sanya aquarium was officially inaugurated. Sea turtles with minor injuries are treated and released back into the sea upon full recovery, while those unable to return to the wild are given a permanent home at the shelter. Covering an area of 388 square meters, the Sea Turtle Shelter features rehabilitation pools, an educational exhibition hall, and breeding beaches designed to replicate a natural ecosystem, offering both a recovery space and long-term habitat for sea turtles.

Driven by Innovation, Committed to Social Contribution

Fosun adheres to an innovation-driven strategy. Its Health segment has developed anticancer and antimalarial drugs that have widely benefited cancer patients and severe malaria patients. Among them, HANSIZHUANG, HLX43, HLX22, and other marketed and pipeline innovative drugs have delivered several “world’s first” breakthroughs. HANSIZHUANG became the world’s first monoclonal antibody targeting PD-1 approved for first-line treatment of extensive-stage small cell lung cancer (ES-SCLC), and has been approved for marketing in over 40 countries and regions. HLX43 has shown significant advantages, with a favorable efficacy and safety profile in non-small cell lung cancer (NSCLC), gynecological tumors, esophageal squamous cell carcinoma (ESCC), and other indications. HLX22 is the world’s first anti-HER2-targeted therapy to receive Orphan Drug Designation (ODD) approvals from both U.S. Food and Drug Administration (FDA) and the European Commission (EC) for gastric cancer. As of 31 December 2025, Fosun Pharma’s independently developed artesunate for injection had saved more than 88 million severe malaria patients worldwide, with more than 440 million doses supplied globally.

In order to better promote the fulfillment and implementation of corporate social responsibility, Fosun Foundation was established in 2012. It has been making unremitting efforts in the fields of global emergency relief, rural revitalization, health, education, culture and art, youth development, to create social value. Among these efforts, the Rural Doctors Program, launched in 2017, has covered 78 counties in 16 provinces, cities, and autonomous regions across the country, supporting 25,000 rural doctors and benefiting 3 million rural families.

Looking ahead, Fosun remains dedicated to advancing its social responsibility through innovation and responsible global operations. Guided by its “Create IMPACT” sustainable development strategy, Fosun will intensify its efforts to build a more responsible, inclusive, and sustainable future.

FSMOne Malaysia Clients’ Unit Trust Investments Returned an Average of 18.8% Over the Past Year

KUALA LUMPUR, Malaysia, July 2, 2026 /PRNewswire/ — For the first time, FSMOne Malaysia has published what its individual clients’ unit trust investments actually returned. Over the 12 months from 1 June 2025 to 31 May 2026, those investments returned an average of 18.8%, net of sales charges and fund management fees. The figure was shared at FSMOne Malaysia’s Recommended Unit Trusts Awards 2026/27, held at W Kuala Lumpur.

The 18.8% covers clients’ full unit trust holdings, from money market and fixed income to balanced and equity funds and is measured across all FSMOne individual client accounts with unit trust investments.

Over the same period, unit trust investments held through the Private Retirement Scheme (PRS) returned an average of 25.37%, while unit trust investments made with EPF savings through the EPF Members Investment Scheme returned an average of 16.5%.

Over the year, FSMOne clients’ unit trust investments carried notable exposure to Asia, Japan, the technology sector and gold. Asia and technology were among the markets and themes where FSMOne’s research held a constructive view throughout the period, and that positioning is reflected in the results.

FSMOne Malaysia General Manager, Mr Koh Soo Cheng said, “Two decisions shape an investor’s outcome more than any other: what to invest in, and where. This year, we are sharing what those decisions delivered for our clients.”

“Those returns came from getting two things right, choosing quality funds and being in the right markets, which is exactly what we help investors do: our Recommended Unit Trusts list takes the work out of fund selection, and our research points to where the opportunities are.”

The Awards recognised 43 funds across 35 categories, covering asset classes, geographies, and both conventional and Islamic strategies, with 15 fund houses among this year’s winners. The full list is available at www.fsmone.com.my.

FSMOne Assistant Manager, Research, Mr Kevin Khaw said, “Global markets have delivered strong returns despite concerns surrounding trade tensions, geopolitical developments, fiscal deficits, and the interest rate outlook. However, one characteristic of this rally has been the growing concentration of returns among a relatively small group of companies and sectors.”

Khaw noted that investors should look beyond the handful of US mega-cap beneficiaries within the Digital Economy theme. “The next phase of growth is likely to create opportunities across semiconductors, digital platforms, cloud infrastructure, software, data centre enablers, and the broader AI ecosystem.”

While the US remains a key focus, Khaw added that Asia presents broader opportunities backed by improved earnings and reasonable valuations. Several markets within the region could benefit from structural reforms, technological advancement, and increasing capital flows.

He highlighted that Singapore stands out for investors who are seeking quality and resilience. “Investors are effectively being paid to wait, with attractive dividend yields, while a strong banking sector, healthy corporate balance sheets, and ongoing capital market initiatives support long-term earnings growth.”

While challenges remain, China’s supportive policy measures signal renewed opportunities. FSMOne remains constructive on artificial intelligence, advanced manufacturing and digital innovation sectors.

Meanwhile, corporate governance reforms and structural changes continue to strengthen Japan’s long-term investment case.

Overall, FSMOne maintains a constructive outlook on Asia as a major beneficiary of supply chain diversification, technological investment, and regional capital flows. Fixed income continues to offer real income and diversification benefits.

“Following the strong rally across global equities, technology, and Asian markets this year, investors should not overlook the importance of portfolio reviews and rebalancing. While long-term opportunities remain attractive, maintaining appropriate asset allocation and risk discipline is often more important than attempting to maximise returns from the latest market winner,” Khaw concluded.

About FSMOne Malaysia & iFAST Capital

FSMOne Malaysia (previously known as Fundsupermart.com Malaysia) is a Multi-Asset Investment Platform under iFAST Capital Sdn. Bhd. (“iFAST Capital”), established in Malaysia since 2008.

iFAST Capital is a subsidiary of iFAST Malaysia Sdn. Bhd. which is wholly owned by iFAST Corporation Ltd. (“iFAST Corporation”). Incorporated in 2000 and listed on the Singapore Exchange Mainboard in December 2014, iFAST Corporation operates in Singapore, Hong Kong, Malaysia, Mainland China and the UK.

Media Contact:

Chin Ru Shi | +6019 266 2666 | rushi@ifastfinancial.com / ir@ifastfinancial.com

Visit www.fsmone.com.my for more details.